Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Baxter International's share price for the quarter that ended in Mar. 2026 was MXN310. Baxter International's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 516 Mil. Therefore, Baxter International's market cap for the quarter that ended in Mar. 2026 was MXN160,099 Mil.
Baxter International's quarterly market cap
declined
from Sep. 2025 (MXN238,671 Mil) to Dec. 2025 (MXN172,603 Mil) and
declined
from Dec. 2025 (MXN172,603 Mil) to Mar. 2026 (MXN160,099 Mil).
Baxter International's annual market cap
declined
from Dec. 2023 (MXN380,725 Mil) to Dec. 2024 (MXN300,737 Mil) and
declined
from Dec. 2024 (MXN300,737 Mil) to Dec. 2025 (MXN172,603 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Baxter International's Enterprise Value for Today is MXN330,963 Mil.
Baxter International (MEX:BAX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Baxter International Market Cap Related Terms
Baxter International Market Cap Historical Data
* Premium members only.
The historical data trend for Baxter International's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Baxter International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baxter International Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Market Cap distribution charts can be found below:
* The bar in red indicates where Baxter International's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Baxter International's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baxter International (MEX:BAX) has a Market Cap of MXN196,212 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Baxter International and its competitors. According to the industry distribution chart, Baxter International ranks #35 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 4%.
Is Baxter International's Market Cap too high?
Baxter International's current Market Cap is MXN196,212 Mil. Based on the distribution chart, Baxter International ranks #35 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Baxter International has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Market Cap compare to COO and ATR?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #35 out of 866 companies for Market Cap. This places Baxter International in the top 4% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.29, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Baxter International and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baxter International's current Market Cap is MXN196,212 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (MEX:BAX) is currently considered Possible Value Trap. The stock's GF Value™ is MXN624.41, compared to a current price of MXN368.89 — trading 40.9% below its estimated fair value. The current Market Cap is MXN196,212 Mil. Baxter International's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Baxter International (MEX:BAX), the current Market Cap is MXN196,212 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baxter International (MEX:BAX) Overvalued in 2026?
Based on GuruFocus' analysis, Baxter International stock appears to be undervalued.
The current stock price of MXN368.89 is trading 40.9% below its estimated GF Value™ of MXN624.41.
GuruFocus considers Baxter International to be Possible Value Trap.
Key valuation signals for MEX:BAX:
Market Cap: MXN196,212 Mil
GF Value™: MXN624.41 vs. price of MXN368.89 (40.9% below fair value)
No single metric tells the full story. See the MEX:BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
44GF Score
Get the complete analysis for MEX:BAX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BAX has been successfully added to your 
